Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,270,723
+$694,804 QoQ
Shares Held
17,671
+34.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,507
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Trivium Point Advisory, LLC holds $28,456,605 across 8 Drug Manufacturers - General names. MRK ranks #4 (8.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
13,340 | $16,000,397 | |
| 2 | JNJ |
Johnson & Johnson
|
12,027 | $3,054,497 | |
| 3 | ABBV |
AbbVie Inc.
|
10,728 | $2,699,593 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
17,671 | $2,270,723 | |
| 5 | AMGN |
Amgen Inc
|
3,478 | $1,259,453 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
20,481 | $1,180,115 | |
| 7 | PFE |
Pfizer Inc
|
45,408 | $1,093,424 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,111 | $898,403 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,270,723 | 17,671 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,575,919 | 13,101 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,648,687 | 15,663 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,269,609 | 15,127 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,290,941 | 16,308 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,265,256 | 14,096 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,522,541 | 15,305 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,618,002 | 14,248 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,960,992 | 15,840 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,054,857 | 15,573 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,810,495 | 16,607 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,830,039 | 17,776 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $2,076,327 | 17,994 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $2,357,283 | 22,157 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $2,413,828 | 21,756 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,873,196 | 21,751 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,216,707 | 24,314 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,035,168 | 24,804 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,709,991 | 22,312 | Shares | Sole | 2022-02-18 | |
| 2021-09-30 | $1,676,905 | 22,326 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,775,955 | 22,836 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,848,002 | 23,972 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,043,608 | 24,983 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,090,506 | 25,202 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $1,959,233 | 25,336 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,926,038 | 25,033 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||